Literature DB >> 12489851

Antisense oligonucleotides: basic concepts and mechanisms.

Nathalie Dias1, C A Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12489851

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  226 in total

1.  Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.

Authors:  Kaneez Fatima; Rehan Zafar Paracha; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

2.  Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.

Authors:  Christina Reufsteck; Rinat Lifshitz-Shovali; Michael Zepp; Tobias Bäuerle; Dieter Kübler; Gershon Golomb; Martin R Berger
Journal:  Clin Exp Metastasis       Date:  2012-03-11       Impact factor: 5.150

3.  Imaging native beta-actin mRNA in motile fibroblasts.

Authors:  Sanjay Tyagi; Osama Alsmadi
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

4.  Dual FRET molecular beacons for mRNA detection in living cells.

Authors:  Philip J Santangelo; Brent Nix; Andrew Tsourkas; Gang Bao
Journal:  Nucleic Acids Res       Date:  2004-04-14       Impact factor: 16.971

5.  Antisense tools for functional studies of human Argonaute proteins.

Authors:  Alessandra Mescalchin; Anke Detzer; Ulrike Weirauch; Maximilian J Hahnel; Christina Engel; Georg Sczakiel
Journal:  RNA       Date:  2010-10-08       Impact factor: 4.942

Review 6.  Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.

Authors:  Maria Moccia; Mauro F A Adamo; Michele Saviano
Journal:  Artif DNA PNA XNA       Date:  2016-01-11

Review 7.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

Review 8.  Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases.

Authors:  Giulietta Riboldi; Chiara Zanetta; Michela Ranieri; Monica Nizzardo; Chiara Simone; Francesca Magri; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Mol Neurobiol       Date:  2014-05-09       Impact factor: 5.590

9.  Gas-phase dissociation of homo-DNA oligonucleotides.

Authors:  Silvan R Stucki; Camille Désiron; Adrien Nyakas; Simon Marti; Christian J Leumann; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2013-09-17       Impact factor: 3.109

10.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.